View Older Stories
-
New drugs contribute to AbbVie's upbeat 2020 view; shares hit year-high
-
Dealmakers eye cross-border M&A recovery as mega mergers roll on
-
Citi Reiterates Buy Rating on Novartis (NVS)
-
UPDATE: Citi Upgrades Abbvie (ABBV) to Buy
-
U.S. dominates second quarter global M&A as mega deals roll on
-
Pre-Open Movers 06/25: (AGN) (PHUN) (PYX) (GRUB) (ALDX) (ABBV) (BHF) (AKRX) (more)
-
AbbVie (ABBV) Announces Agreement to Acquire Allergan (AGN) in $63 Billion Deal
-
AbbVie to Acquire Allergan in Transformative Move for Both Companies
-
S&P 500 Q2 2018 Buybacks Increase 58.7% Year-Over-Year to Record $190.6 Billion
-
Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more...) -13F
-
Abbvie (ABBV) PT Raised to $96 at Citi
-
Glenview Capital 13F Shows New Stakes in Allergan (AGN), Newell (NWL), Charter (CHTR) Aramark (ARMK) (More...)
-
Abbvie (ABBV) PT Raised to $93 at Citi; Remains sidelined
-
Glenview Capital Enters Comcast (CMCSA), CVS (CVS), Twitter (TWTR) (more...) - 13F
-
Glenview Capital's 13F Shows New Stakes in Hain Celestial (HAIN), Shire (SHPG), T-Mobile (TMUS) (More...)
-
Glenview Capital Enters eBay (EBAY), Lowe's (LOW), Visa (V), Walgreens (WBA) (more...) - 13F
-
Citi Downgrades Abbvie (ABBV) to Neutral
-
Robbins' Glenview Capital 13F Shows New Stakes in Endo (ENDP), Hewlett Packard Enterprise (HPE), Platform Specialty (PAH), Increase in First Data (FDC) (More...)
-
Complete Donald Trump Stock Impact Guide
-
Glenview Capital Sells Abbvie (ABBV), CBS (CBS) in Q2; Adds DuPoint (DD), Marvell (MRVL) - 13F
-
Glenview Capital Enters Advance Auto Parts (AAP), Fidelity National Information (FIS) (more...) - 13F
-
Notable Analyst Rating Changes 2/23: (ABBV) (TWTR) (NLY) Upgraded; (EVEP) (FCX) (X) Downgraded
-
Citi Upgrades Abbvie (ABBV) to Buy
-
Drugmaker Shire to buy Baxalta for $32 billion after six-month pursuit
-
Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources
-
Glenview Capital Enters Kindred Health (KND), Sirius XM (SIRI) (more...)
-
Notable Analyst Rating Changes 11/2: (MGM) (ABBV) (KEY) Upgraded; (JMEI) (SBRA) (ANET) Downgraded
-
Citi Upgrades Abbvie (ABBV) to Neutral
-
Robbins' Glenview Capital 13F Shows New Stakes in Bank of New York (BK), Comcast (CMCSA), Hubbell (HUB-B), Sells Fox (FOXA)
-
Notable Analyst Rating Changes 7/22: (AMZN) (AUY) (JCP) Upgraded; (ABG) (UTC) (CHK) Downgraded
-
Robbins Glenview Capital Buys AbbVie (ABBV), McDonald's (MCD), Trims Aetna (AET), GM (GM), CBS (CBS) - 13F
-
Viking Global Shows New Stakes in AMBEV (ABEV), Anthem (ANTM) NXP Semi (NXPI) (more...)
-
Streetinsider.com's Hot Lunchtime Reads 2/9: (AMD) (TWTR) (KORS) (GOOG)
-
UPDATE: Citi Starts Abbvie (ABBV) at Sell on Concerns Related to Biosimilars
-
Notable Analyst Rating Changes 2/9: (MOS) (PFE) (AMC) Upgraded; (CENX) (ANF) (RF) Downgraded
-
Pre-Open Stock Movers 01/20: (UNIS) (SWHC) (MRCL) Higher; (FXCM) (EXPR) (OUTR) Lower (more...)
-
Streetinsider.com's Hot Lunchtime Reads 1/16: (CYTX) (FB) (AAPL) (C) (INTC)
-
Notable Analyst Rating Changes 10/21: (GPOR) (ILMN) (POST) Upgraded; (ABBV) (IBM) (BHP) Downgraded
-
Notable Mergers and Acquisitions of the Day 07/18: (GTIV) (ABBV)/(SHPG) (TWTR) (RDNT)
-
AbbVie (ABBV) to Acquire Shire (SHPG) for ~$54B
-
Market Wrap: Citi Trounces Q2 Expectations; Merger Monday; Drug Stocks Active on Results
-
Pre-Open Stock Movers 6/20: (SHPG) (KMX) (ACHN) Higher; (MACK) (SWHC) (ORCL) Lower (more...)
-
Notable Analyst Rating Changes 05/07: (JCP) (ABBY) (FE) Upgraded; (WFM) (GNC) (GRPN) Downgraded
-
Notable Analyst Rating Changes 08/12: (FFIV) (CVC) (LKQ) Upgraded; (TSLA) (VOYA) (JNPR) Downgraded
-
Nokia (NOK), Sprint (S) See Largest Short-Interest Gains on NYSE Through 01/15/13
-
Notable Analyst Rating Changes 01/04: (JNJ) (ZQK) (AVP) Upgraded; (LULU) (MSFT) (ABT) Downgraded